CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Operating activities:
Net income attributable to common shareholders	$ 133.3	$ 335.6	$ 171.8
Noncontrolling interest in subsidiaries' earnings (loss)	0.3	(0.1)	0.7
Net income before allocation to noncontrolling interests	133.6	335.5	172.5
Asbestos provision, net	229.0	0.0	0.0
Environmental provision, net	18.9	0.0	0.0
Loss (gain) on deconsolidation of joint venture	1.2	1.7	(1.0)
Realized gain on marketable securities	1.1
Gain on sale of property related to facility consolidation			(11.1)
Depreciation and amortization	113.5	120.0	72.7
Stock-based compensation expense	22.3	21.6	21.8
Defined benefit plans and postretirement credit	(0.7)	(15.0)	(8.5)
Deferred income taxes	(25.1)	47.7	102.3
Cash (used for) provided by operating working capital	(40.0)	16.3	54.0
Defined benefit plans and postretirement contributions	(8.7)	(59.8)	(13.2)
Environmental payments, net of reimbursements	(8.2)	(6.3)	(6.3)
Payments for asbestos-related fees and costs, net of insurance recoveries	(41.5)	(63.9)	(62.5)
Other	0.7	16.0	(3.2)
Total provided by operating activities	393.9	413.8	317.5
Investing activities:
Capital expenditures	(68.8)	(108.8)	(49.0)
Proceeds from disposition of capital assets	3.1	1.9	22.3
Payments for acquisitions, net of cash acquired	(156.2)	(648.0)	(54.8)
Impact of deconsolidation of joint venture	(0.2)	2.6	(5.2)
Purchase of marketable securities	(8.8)
Proceeds from sale of marketable securities	9.9
Total used for investing activities	(221.0)	(752.3)	(86.7)
Financing activities:
Dividends paid	(93.2)	(83.5)	(78.4)
Reacquisition of shares on open market	(79.9)	(50.1)	(25.0)
Stock options exercised, net of shares reacquired	2.9	16.1	25.2
Debt issuance costs		(5.4)	(2.6)
Repayment of long-term debt	(99.4)	(452.2)
Repayment of short-term debt	(7.4)	(100.0)
Proceeds from issuance of long-term debt	3.0	567.2
Proceeds from issuance of short-term debt		100.0
Net proceeds from issuance of commercial paper with maturities of 90 days or less	124.4
Proceeds from Issuance of Commercial Paper	25.0
Total used for financing activities	(124.6)	(7.9)	(80.8)
Effect of exchange rates on cash and cash equivalents	2.2	(16.4)	46.5
Increase (decrease) in cash and cash equivalents	50.5	(362.8)	196.5
Cash and cash equivalents at beginning of period	343.4	706.2	509.7
Cash and cash equivalents at end of period	393.9	343.4	706.2
Detail of cash (used for) provided by operating working capital:
Accounts receivable	3.8	4.8	(10.1)
Inventories	(8.3)	(38.8)	6.4
Other current assets	(1.3)	(11.4)	0.8
Accounts payable	(23.4)	37.0	17.5
Accrued liabilities	(35.2)	40.9	30.8
U.S. and foreign taxes on income	24.4	(16.2)	8.6
Cash (used for) provided by operating working capital	(40.0)	16.3	54.0
Supplemental disclosure of cash flow information:
Interest paid	47.4	47.5	36.0
Income taxes paid	$ 37.9	$ 58.4	$ 84.1